Advances in Immunotherapy in Esophagogastric Cancer

被引:1
|
作者
Jazieh, Khalid [1 ]
Yoon, Harry [1 ]
Zhu, Mojun [1 ]
机构
[1] Mayo Clin, Div Med Oncol, 200 First St Southwest, Rochester, MN 55905 USA
关键词
Immunotherapy; Immune checkpoint inhibitor; PD-1; PD-L1; Esophageal; Gastroesophageal; Cancer; Malignancy; GASTROESOPHAGEAL JUNCTION CANCER; PEMBROLIZUMAB PLUS CHEMOTHERAPY; PD-1; BLOCKADE; T-CELLS; DOUBLE-BLIND; PHASE-I; ESOPHAGEAL; NIVOLUMAB; EXPRESSION; RADIOTHERAPY;
D O I
10.1016/j.hoc.2024.02.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:599 / 616
页数:18
相关论文
共 50 条
  • [41] Current advancements and future perspectives of immunotherapy in colorectal cancer research
    Kishore, Chandra
    Bhadra, Priyanka
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 893
  • [42] Advances in cancer immunotherapy 2019-latest trends
    Kruger, Stephan
    Ilmer, Matthias
    Kobold, Sebastian
    Cadilha, Bruno L.
    Endres, Stefan
    Ormanns, Steffen
    Schuebbe, Gesa
    Renz, Bernhard W.
    D'Haese, Jan G.
    Schloesser, Hans
    Heinemann, Volker
    Subklewe, Marion
    Boeck, Stefan
    Werner, Jens
    von Bergwelt-Baildon, Michael
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
  • [43] Advances in immunotherapy for triple-negative breast cancer
    Liu, Yang
    Hu, Yueting
    Xue, Jinqi
    Li, Jingying
    Yi, Jiang
    Bu, Jiawen
    Zhang, Zhenyong
    Qiu, Peng
    Gu, Xi
    MOLECULAR CANCER, 2023, 22 (01)
  • [44] Immunotherapy in Esophagogastric Cancer: Treatment Landscape, Challenges, and New Directions
    Nicole Baranda Balmaceda
    Sunnie S. Kim
    Journal of Gastrointestinal Cancer, 2024, 55 : 153 - 167
  • [45] Advances and challenges in immunotherapy of small cell lung cancer
    Guo, Hanfei
    Li, Lingyu
    Cui, Jiuwei
    CHINESE JOURNAL OF CANCER RESEARCH, 2020, 32 (01) : 115 - 128
  • [46] Recent Advances in Immunotherapy for Advanced Biliary Tract Cancer
    Yue, Shiwei
    Zhang, Yunpu
    Zhang, Wei
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2024, 25 (08) : 1089 - 1111
  • [47] Prognostic characteristics and clinical response to immunotherapy targeting programmed cell death 1 for patients with advanced gastric cancer with liver metastases
    Liang, Huayuan
    Li, Zhiwei
    Huang, Zhicheng
    Wu, Chaorui
    Qiu, Yaopeng
    Liang, Yanrui
    Chen, Xinhua
    Li, Fengping
    Xu, Zhou
    Li, Guoxin
    Liu, Hao
    Zhao, Liying
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [48] Immunotherapy Predictive Molecular Markers in Advanced Gastroesophageal Cancer: MSI and Beyond
    Park, Robin
    Da Silva, Laercio Lopes
    Saeed, Anwaar
    CANCERS, 2021, 13 (07)
  • [49] Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer
    Agostinetto, Elisa
    Losurdo, Agnese
    Nader-Marta, Guilherme
    Santoro, Armando
    Punie, Kevin
    Barroso, Romualdo
    Popovic, Lazar
    Solinas, Cinzia
    Kok, Marleen
    de Azambuja, Evandro
    Lambertini, Matteo
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (06) : 567 - 591
  • [50] Role of Immunotherapy in Gastroesophageal Cancers-Advances, Challenges and Future Strategies
    Lynch, Emer
    Duffy, Austin G.
    Kelly, Ronan J.
    CANCERS, 2023, 15 (22)